Letter abstract
Nature Cell Biology 9, 428 - 435 (2007)
Published online: 18 March 2007 | doi:10.1038/ncb1562
C-terminal modifications regulate MDM2 dissociation and nuclear export of p53
Stephanie Carter1, Oliver Bischof2, Anne Dejean2 & Karen H. Vousden1
p53 functions to prevent malignant progression, in part by inhibiting proliferation or inducing the death of potential tumour cells1. One of the most important regulators of p53 is MDM2, a RING domain E3 ligase that ubiquitinates p53, leading to both proteasomal degradation and relocation of p53 from the nucleus to the cytoplasm1. Previous studies have suggested that although polyubiquitination is required for degradation, monoubiquitination of p53 is sufficient for nuclear export2. Using a p53–ubiquitin fusion protein we show that ubiquitination contributes to two steps before export: exposure of a carboxy-terminal nuclear export sequence (NES), and dissociation of MDM2. Monoubiquitination can directly promote further modifications of p53 with ubiquitin-like proteins and MDM2 promotes the interaction of the SUMO E3 ligase PIASy with p53, enhancing both sumoylation and nuclear export. Our results suggest that modifications such as sumoylation can regulate the strength of the p53–MDM2 interaction and participate in driving the export of p53.
- The Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
- Institut Pasteur, INSERM U.579, 28 Rue du Dr. Roux, 75724 Paris Cedex 15, France.
Correspondence to: Karen H. Vousden1 e-mail: k.vousden@beatson.gla.ac.uk
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Mdm2?SUMO1: is bigger better?Nature Cell Biology News and Views (01 Sep 2000)
A peek at PIASNature Immunology News and Views (01 Sep 2004)
RESEARCH
Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteinsThe EMBO Journal Article (19 Sep 2007)
See all 46 matches for Research